Phase 1 Evaluation of (11)C-CS1P1 to Assess Safety and Dosimetry in Human Participants. Brier MR, Hamdi M, Rajamanikam J, Zhao H, et al. J Nucl Med 2022;63:1775-1782.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Brier MR, Hamdi M, Rajamanikam J, Zhao H, et al. Phase 1 Evaluation of (11)C-CS1P1 to Assess Safety and Dosimetry in Human Participants. J Nucl Med 2022;63:1775-1782.
PMID: 35332093